Weight loss

GLP-1 · Eli Lilly

Foundayo (orforglipron)

Once-daily oral GLP-1 receptor agonist FDA-approved on April 1, 2026 for long-term weight management in eligible adults, alongside a reduced-calorie diet and increased physical activity. FDA approval does not establish an Ondoc prescribing program or pharmacy availability.

FDA-approved for

  • Long-term weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity

Cash reference: Check current pharmacy pricing

Why Ondoc for Foundayo

  • Discuss medication options through the existing weight-management visit
  • Insurance coverage depends on your individual plan
  • No prescription or pharmacy availability is guaranteed

Common questions about Foundayo

Can I use insurance for weight management with Ondoc?

Ondoc accepts Medicare and supported commercial insurance for clinical care; coverage for your weight-management visit is verified for your individual plan and service. General weight-management visits are $50 self-pay; the existing Qsymia evaluation is $100. Medication coverage depends on your plan.

Does Ondoc prescribe Wegovy, Zepbound or other GLP-1s?

Ondoc treats weight management, and GLP-1 medications such as Wegovy and Zepbound are among the options. Your Ondoc clinician decides what fits you.

Do I need a membership or subscription?

No. You can book a one-time visit. A membership is optional.

How do I start?

Pick insurance or self-pay, choose an available appointment time, and book.

Are compounded GLP-1s an option?

Ondoc prescribes FDA-approved GLP-1 medications and does not route these drugs to compounding pharmacies.